Labcorp's Anjen Chenn speaks about FGFR molecular testing
Update: 2019-08-15
Description
At ASCO 2019, LabCorp's Senior Director for Molecular Oncology Anjen Chenn, MD Ph.D, speaks about FGFR testing solutions from QIAGEN and how it works. He also answers the question: Why does Day One Lab Readiness matter?
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
